About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Cbfbtm1Spe
targeted mutation 1, Nancy A Speck
MGI:1934195
Summary 4 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
hm1
Cbfbtm1Spe/Cbfbtm1Spe either: (involves: 129S4/SvJae * BALB/c) or (involves: 129S4/SvJae * C57BL/6) MGI:3588736
ht2
Cbfbtm1Spe/Cbfbtm2.1Spe involves: 129S4/SvJae MGI:3721372
cx3
Cbfbtm1Spe/Cbfbtm1Spe
Tg(Tek-GFP/Cbfb)1Spe/0
either: (involves: 129S4/SvJae * BALB/c * CD-1) or (involves: 129S4/SvJae * C57BL/6 * CD-1) MGI:2653200
cx4
Cbfbtm1Spe/Cbfbtm1Spe
Tg(Tek-GFP/Cbfb)2Spe/0
either: (involves: 129S4/SvJae * BALB/c * CD-1 * Swiss Webster) or (involves: 129S4/SvJae * C57BL/6 * CD-1 * Swiss Webster) MGI:2653204


Genotype
MGI:3588736
hm1
Allelic
Composition
Cbfbtm1Spe/Cbfbtm1Spe
Genetic
Background
either: (involves: 129S4/SvJae * BALB/c) or (involves: 129S4/SvJae * C57BL/6)
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Cbfbtm1Spe mutation (0 available); any Cbfb mutation (36 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• homozygotes die between E11.5 and E14.5

cardiovascular system
• at E10.5, apoptosis and perivascular edema appear to be associated with sprouting and/or anastomosing capillaries of the affected region
• at E10.5, homozygotes exhibit extensive hemorrhages predominantly in the CNS
• at E11.5, homozygotes display segmental bleeds in the areas corresponding to the VII/VIII cranial nerve complex
• at E11.5, homozygotes exhibit hemorrhages in the lateral, third and fourth ventricles
• at E11.5, homozygotes display hemorrhagic lesions in intersegmental regions along the presumptive spinal cord

nervous system
• at E11.5, homozygotes display segmental bleeds in the areas corresponding to the VII/VIII cranial nerve complex
• at E11.5, homozygotes exhibit hemorrhages in the lateral, third and fourth ventricles
• at E11.5, homozygotes display hemorrhagic lesions in intersegmental regions along the presumptive spinal cord

cellular
• apoptosis or necrosis appears to precede hemorrhaging in affected sites
• at E10.5, homozygotes exhibit increased apoptosis in hemorrhagic lesions of the CNS and in cephalic mesodermal tissue

homeostasis/metabolism
• at E10.5, homozygotes display perivascular edema

hematopoietic system
• homozygotes exhibit impaired fetal liver hematopoiesis; in contrast, primitive yolk-sac derived hematopoiesis is unaffected
• at E12.5, mutant fetal livers lack blood precursor cells in the sinusoids; instead, primary nucleated yolk-sac derived erythrocytes are present and only a few hematopoietic precursors are found
• at E12.5, the number of blast-like progenitors of definitive erythroid and myeloid cells is ~100-fold lower in mutant livers relative to wild-type
• at E12.5, homozygotes contain severely reduced definitive erythroblasts in peripheral blood




Genotype
MGI:3721372
ht2
Allelic
Composition
Cbfbtm1Spe/Cbfbtm2.1Spe
Genetic
Background
involves: 129S4/SvJae
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Cbfbtm1Spe mutation (0 available); any Cbfb mutation (36 available)
Cbfbtm2.1Spe mutation (0 available); any Cbfb mutation (36 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• die within the first day after birth although born at normal Mendelian ratios

skeleton
• reduced primary ossification and delayed appearance of secondary ossification centers
• increased severity
• delayed ossification of ribs, metacarpal/metatarsal bones, phalanges, pelvis, sternum, vertebrae
• hypoplastic clavicles, scapulae, calvaria, maxillae, mandibles
• increased severity

hematopoietic system
• lower percentage of double positive T cells and absolute numbers reduced 100 fold
• increased levels of CD4 expressing cells
• small size
• reduced cellularity
• transition from early T-lineage to DN2 stage severely impaired
• DN2 to DN3 transition severely impaired
• lower percentage of double positive T cells and absolute numbers reduced 100 fold
• half the number of hematopoietic cells in the fetal liver at E12.5
• reversed at E17.5
• colonies in culture are denser with smaller cells
• reduced numbers of platelets both in culture and in the circulation
• increased levels of CD4 expressing T cells but not typical CD4+ cells
• 4-5 fold reduction in CD45+ numbers
• 10-20 fold reduction in monocyte/granulocytes
• CD19+ B cells and Ter119 erythrocyte numbers are reduced but proportionally normal

immune system
• lower percentage of double positive T cells and absolute numbers reduced 100 fold
• increased levels of CD4 expressing cells
• small size
• reduced cellularity
• transition from early T-lineage to DN2 stage severely impaired
• DN2 to DN3 transition severely impaired
• lower percentage of double positive T cells and absolute numbers reduced 100 fold
• increased levels of CD4 expressing T cells but not typical CD4+ cells
• 4-5 fold reduction in CD45+ numbers
• 10-20 fold reduction in monocyte/granulocytes
• CD19+ B cells and Ter119 erythrocyte numbers are reduced but proportionally normal

craniofacial

limbs/digits/tail

endocrine/exocrine glands
• lower percentage of double positive T cells and absolute numbers reduced 100 fold
• increased levels of CD4 expressing cells
• small size
• reduced cellularity




Genotype
MGI:2653200
cx3
Allelic
Composition
Cbfbtm1Spe/Cbfbtm1Spe
Tg(Tek-GFP/Cbfb)1Spe/0
Genetic
Background
either: (involves: 129S4/SvJae * BALB/c * CD-1) or (involves: 129S4/SvJae * C57BL/6 * CD-1)
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Cbfbtm1Spe mutation (0 available); any Cbfb mutation (36 available)
Tg(Tek-GFP/Cbfb)1Spe mutation (0 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
cellular
• bone collar shows few differentiating osteoblasts

mortality/aging

craniofacial

hematopoietic system
• thymus is small and contains 50% fewer cells than in wild-type
• fetal livers contain 50% as many colony forming unit (CFU)-granulocyte/erythroid/monocyte/macrophage (GEMM) progenitors as do wild-type
• overall increase in the proportion of red blood cell precursors from 38% to 79% of nucleated cells at E17.5
• few mature myeloid cells are present
• ratio of erythroid precursors to myeloid precursors is increased from 0.48 in wild-type fetuses to 1.22 in mutant fetuses at E17.5
• increase in numbers of single CD4+ cells in thymuses
• 2-fold increase in hematopoietic progenitors
• spleens are hypocellular, but overall structure and organization is normal
• fewer B220+ cells, GR-1+ neutrophils and Mac-1+ cells in E17.5 spleens

immune system
• thymus is small and contains 50% fewer cells than in wild-type
• few mature myeloid cells are present
• increase in numbers of single CD4+ cells in thymuses
• spleens are hypocellular, but overall structure and organization is normal
• fewer B220+ cells, GR-1+ neutrophils and Mac-1+ cells in E17.5 spleens

skeleton
• bone collar shows few differentiating osteoblasts
• delay in chondrocyte maturation
• ossification of the limbs, ribs and vertebra is delayed at E17.5
• intramembranous bone formation is initiated but is either prematurely terminated or delayed at an early stage of osteoblast differentiation

vision/eye
• delay in or incomplete closure of the eyelids

digestive/alimentary system

limbs/digits/tail

liver/biliary system
• decrease in the percentage of CD19+ and B220+ B cells, GR1+ neutrophils and Mac-1+ cells in fetal liver

endocrine/exocrine glands
• thymus is small and contains 50% fewer cells than in wild-type

growth/size/body




Genotype
MGI:2653204
cx4
Allelic
Composition
Cbfbtm1Spe/Cbfbtm1Spe
Tg(Tek-GFP/Cbfb)2Spe/0
Genetic
Background
either: (involves: 129S4/SvJae * BALB/c * CD-1 * Swiss Webster) or (involves: 129S4/SvJae * C57BL/6 * CD-1 * Swiss Webster)
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Cbfbtm1Spe mutation (0 available); any Cbfb mutation (36 available)
Tg(Tek-GFP/Cbfb)2Spe mutation (0 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
cellular
• bone collar shows few differentiating osteoblasts

mortality/aging

craniofacial

hematopoietic system
• thymus is small and contains 50% fewer cells than in wild-type
• fetal livers contain 50% as many colony forming unit (CFU)-granulocyte/erythroid/monocyte/macrophage (GEMM) progenitors as do wild-type
• overall increase in the proportion of red blood cell precursors from 38% to 79% of nucleated cells at E17.5
• few mature myeloid cells are present
• ratio of erythroid precursors to myeloid precursors is increased from 0.48 in wild-type fetuses to 1.22 in mutant fetuses at E17.5
• increase in numbers of single CD4+ cells in thymuses
• 2-fold increase in hematopoietic progenitors
• spleens are hypocellular, but overall structure and organization is normal
• fewer B220+ cells, GR-1+ neutrophils and Mac-1+ cells in E17.5 spleens

immune system
• thymus is small and contains 50% fewer cells than in wild-type
• few mature myeloid cells are present
• increase in numbers of single CD4+ cells in thymuses
• spleens are hypocellular, but overall structure and organization is normal
• fewer B220+ cells, GR-1+ neutrophils and Mac-1+ cells in E17.5 spleens

skeleton
• bone collar shows few differentiating osteoblasts
• delay in chondrocyte maturation
• ossification of the limbs, ribs and vertebra is delayed at E17.5
• intramembranous bone formation is initiated but is either prematurely terminated or delayed at an early stage of osteoblast differentiation

vision/eye
• delay in or incomplete closure of the eyelids

digestive/alimentary system

limbs/digits/tail

liver/biliary system
• decrease in the percentage of CD19+ and B220+ B cells, GR1+ neutrophils and Mac-1+ cells in fetal liver

endocrine/exocrine glands
• thymus is small and contains 50% fewer cells than in wild-type

growth/size/body





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
04/30/2024
MGI 6.23
The Jackson Laboratory